Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole oral suspension serum concentration study for prevention of invasive fungal infection
ChiCTR1900026294Phase 4Recruiting
- Sponsor
- Soochow University
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of posaconazole in invasive mycoses, sponsored by Soochow University. Primary endpoint: Breakthrough invasive fungal infection after drug use. Started Mar 2017; status: recruiting.
02
Drugs
posaconazole
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on ChiCTR1900026294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026294.